Kotra Industries Bhd (XKLS:0002) EBIT: RM48.2 Mil (TTM As of Mar. 2026)


XKLS:0002 Kotra Industries Bhd XKLS:0002
84 GF Score
Price RM3.71
GF Value RM4.33
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Kotra Industries Bhd EBIT?

Kotra Industries Bhd XKLS:0002 84 EBIT is RM48.2 Mil as of Mar. 2026. GuruFocus rates XKLS:0002 with a GF Score™ of 84/100 and a GF Value™ of RM4.33 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Kotra Industries Bhd's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was RM10.9 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was RM48.2 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Kotra Industries Bhd's annualized ROC % for the quarter that ended in Mar. 2026 was 12.11%. Kotra Industries Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 16.48%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Kotra Industries Bhd's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 9.08%.


Kotra Industries Bhd  (XKLS:0002) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Kotra Industries Bhd's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=43.536 * ( 1 - 25.3% )/( (261.81 + 275.378)/ 2 )
=32.521392/268.594
=12.11 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Kotra Industries Bhd's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=43.536/( ( (221.344 + max(36.262, 0)) + (235.552 + max(35.198, 0)) )/ 2 )
=43.536/( ( 257.606 + 270.75 )/ 2 )
=43.536/264.178
=16.48 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(39.023 + 50.695 + 0.088999999999999) - (53.545 + 0 + 0)
=36.262

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(37.887 + 49.275 + 0.016999999999996) - (51.862 + 0 + 0.119)
=35.198

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Kotra Industries Bhd's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=48.152/530.401
=9.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kotra Industries Bhd EBIT Related Terms


Kotra Industries Bhd EBIT Historical Data

* Premium members only.

The historical data trend for Kotra Industries Bhd's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kotra Industries Bhd EBIT Chart

Kotra Industries Bhd Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.15 58.74 66.27 56.51 51.38

Kotra Industries Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.03 11.94 12.37 12.96 10.88

XKLS:0002 vs ZTS, UTHR, VTRS: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Kotra Industries Bhd's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kotra Industries Bhd EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kotra Industries Bhd's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Kotra Industries Bhd's EV-to-EBIT falls into.


XKLS:0002
84GF Score
Kotra Industries Bhd XKLS:0002
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kotra Industries Bhd EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM48.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of RM48.2 Mil mean?
Kotra Industries Bhd (XKLS:0002) has a EBIT of RM48.2 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Kotra Industries Bhd.
Is Kotra Industries Bhd's EBIT too high?
Kotra Industries Bhd's current EBIT is RM48.2 Mil. Overall, Kotra Industries Bhd has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kotra Industries Bhd's EBIT compare to ZTS and UTHR?
Kotra Industries Bhd's EBIT of RM48.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Kotra Industries Bhd. Kotra Industries Bhd's current EBIT is RM48.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kotra Industries Bhd stock overvalued right now?
Based on GuruFocus' analysis, Kotra Industries Bhd (XKLS:0002) is currently considered Modestly Undervalued. The stock's GF Value™ is RM4.33, compared to a current price of RM3.71 — trading 14.3% below its estimated fair value. The current EBIT is RM48.2 Mil. Kotra Industries Bhd's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Kotra Industries Bhd (XKLS:0002), the current EBIT is RM48.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kotra Industries Bhd (XKLS:0002) Overvalued in 2026?

Based on GuruFocus' analysis, Kotra Industries Bhd stock appears to be undervalued. The current stock price of RM3.71 is trading 14.3% below its estimated GF Value™ of RM4.33. GuruFocus considers Kotra Industries Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0002:

  • EBIT: RM48.2 Mil
  • GF Value™: RM4.33 vs. price of RM3.71 (14.3% below fair value)
  • GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the XKLS:0002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Kotra Industries Bhd Business Description

Address Jalan TTC 12, No. 1, 2 & 3, Cheng Industrial Estate, Melaka, MYS, 75250
Kotra Industries Bhd is a Malaysian pharmaceutical company engaged in the development, manufacturing, and supply of pharmaceutical and healthcare products supporting all life stages. Its portfolio includes life-saving medicines, OTC supplements, and nutrition products. The Group markets three core brands: Appeton, offering health supplements and nutrition across all age groups; Vaxcel, providing injectable medicines for infectious diseases, kidney care, and gastroenterology; and Axcel, specializing in oral and topical medicines for paediatrics, dermatology, and infectious diseases. The company operates in Malaysia and overseas, with the majority of revenue derived from Malaysia.
84GF Score

Get the complete analysis for XKLS:0002

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM3.71
Price
RM4.33
GF Value